Bayer AG's top pharmaceutical products based on revenue 2014-2018

Bayer AG is an international pharmaceutical and agriculture company. As of 2018, their top pharmaceutical product was Xarelto, a blood clot reducing medication used in the treatment of coronary artery disease. During that year Xarelto generated an estimated 3.6 billion U.S. dollars in revenues for Bayer. The second highest revenue generating pharmaceutical for Bayer was Eylea, which generated 2.2 billion U.S. dollars at that time.

Bayer’s company profile

Bayer is a German pharmaceutical and agriculture company with several segments such as Pharmaceuticals and Crop Science. Bayer operates on a global level. Bayer’s largest revenue-generating segment is their pharmaceutical segment, followed by their Crop Science segment. The company’s general revenue increases are reflected in the increases in revenue for Bayer HealthCare in recent years. Bayer is among the top pharmaceutical companies globally.

Global pharmaceuticals

The top pharmaceutical companies based on research and development expenses include big names such as Roche, Johnson & Johnson, and Novartis. These companies rely heavily on the research and development of new drugs. Currently the top pharmaceutical products globally include AbbVie’s Humira, Pfizer’s Eliquis. And Celgene’s Revlimid. The worldwide pharmaceutical market has been growing significantly in recent years and estimates suggest that there will be many new opportunities for these top companies to develop new drugs.